Authors:
RAANANI P
SHPILBERG O
GILIS S
AVIGDOR A
HARDAN I
BERKOWICZ M
SOFER O
LOSSOS I
CHETRIT A
BENYEHUDA D
BENBASSAT I
Citation: P. Raanani et al., SALVAGE THERAPY OF REFRACTORY ACUTE-LEUKEMIA WITH HIGH-DOSE MITOXANTRONE AND CYTARABINE, Blood, 90(10), 1997, pp. 3842-3842
Authors:
SHPILBERG O
SHIMON I
SOFER O
DOLITSKI M
BENBASSAT I
Citation: O. Shpilberg et al., TRANSIENT NORMAL PLATELET COUNTS AND DECREASED REQUIREMENT FOR INTERFERON DURING PREGNANCY IN ESSENTIAL THROMBOCYTHEMIA, British Journal of Haematology, 92(2), 1996, pp. 491-493
Authors:
SHPILBERG O
BLUMENTHAL R
SOFER O
KATZ Y
CHETRIT A
RAMOT B
ELDOR A
BENBASSAT I
Citation: O. Shpilberg et al., A CONTROLLED TRIAL OF TRANEXAMIC ACID THERAPY FOR THE REDUCTION OF BLEEDING DURING TREATMENT OF ACUTE MYELOID-LEUKEMIA, Leukemia & lymphoma, 19(1-2), 1995, pp. 141-144
Authors:
GILLIS S
SOFER O
ZELIG O
DANN EJ
LOTAN H
BENYEHUDA D
ISACSON R
RACHMILEWITZ EA
BENBASSAT I
POLLIACK A
Citation: S. Gillis et al., ACUTE PROMYELOCYTIC LEUKEMIA WITH T(15-17) FOLLOWING TREATMENT OF HODGKINS-DISEASE - A REPORT OF 4 CASES, Annals of oncology, 6(8), 1995, pp. 777-779
Authors:
SHPILBERG O
HADDAD N
SOFER O
RAANANI P
BERKOWICZ M
CHETRIT A
CARTER A
RAMOT B
TATARSKI I
BENBASSAT I
Citation: O. Shpilberg et al., POSTREMISSION THERAPY WITH 2 DIFFERENT DOSE REGIMENS OF CYTARABINE INADULTS WITH ACUTE MYELOGENOUS LEUKEMIA, Leukemia research, 19(12), 1995, pp. 893-897
Authors:
SHPILBERG O
BLUMENTHAL R
SOFER O
ELDOR A
BENBASSAT I
Citation: O. Shpilberg et al., A CONTROLLED TRIAL OF TRANEXAMIC ACID (TA) TREATMENT FOR REDUCTION OFBLEEDING DURING ACUTE MYELOID-LEUKEMIA (AML) INDUCTION AND CONSOLIDATION, Blood, 82(10), 1993, pp. 10000547-10000547